The 4th International Electronic Conference on Metabolomics
The 4th International Electronic Conference on Metabolomics
Part of the International Electronic Conference on Metabolism and Metabolomics series
Event's Timezone: Central European Summer Time
22 August 2025
11 September 2025
9 October 2025
Metabolome, Analysis of Organisms, Metabolomics
Welcome to participate in IECM 2025!
Please be advised that some submissions are still in the process of being reviewed. We kindly ask for your patience as we work through them and will send out notifications shortly. We look forward to sharing the program overview and will reach out to the speakers soon.
Registration remains open, secure your spot and join us for a stimulating conference. Register for free HERE
For any inquiries please contact us at iecm2025@mdpi.com
Welcome from the Chairs
- Clinical Metabolomics: Unlocking Insights for Endocrinological Disorders;
- Pioneering Technological Frontiers in Metabolomics;
- Breaking Barriers with Advanced Data Analysis in Metabolomics;
- Precision Nutrition Meets Metabolomics: Transforming Human and Animal Health;
- Metabolomics in Drug Discovery: Shaping the Future of Pharmacology;
- Microbial Metabolites: Novel Pathways to Health and Therapeutics;
School of Clinical Medicine, University of Cambridge, UK
Program Overview
| Day 1 | Day 2 | Day 3 |
| 13 Oct - Morning | 14 Oct - Morning | 15 Oct - Morning |
| S2: Technological Advances in Metabolomics | S1: Clinical Application of Metabolomics with Special Reference to the Endocrinological Arena | S6: Microbial Metabolites with Novel Functions in Diseases and Health |
| Break | ||
| 13 Oct - Afternoon | 14 Oct - Afternoon | 15 Oct - Afternoon |
| S3: Advanced Metabolomics and Data Analysis Approaches | S5: Applications of Metabolomics in Pharmacology and New Drug Development | S4: Metabolomics for Precision Nutrition in Humans and Animals |
Event Chairs
Department of Food Science and Nutrition, University of Minnesota, Minneapolis, USA
Professor Chen received his PhD in Pharmaceutical Science from Rutgers University and conducted his postdoctoral research at the National Cancer Institute of NIH. He had extensive research experience in metabolomics, nutritional biochemistry, animal metabolism, toxicology, and xenobiotic metabolism. His research focuses on mechanistic characterization of metabolic changes induced by dietary, chemical and pathophysiological challenges in human and animals.
School of Clinical Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
As a strategic consultant at the University of Cambridge, Dr Reza Salek lead translational initiatives in Artificial Intelligence and MedTech program development, with a focus on software and AI as a medical device (SaMD and AIaMD) within regulatory compliance frameworks. Previously, he served as Head of Application Development and Vice President for Bruker’s R&D, directing multidisciplinary teams to advance high-performance applications in medical and analytical devices. His career includes designing scalable workflow solutions for multi-omics data analysis at the International Agency for Research on Cancer (IARC/WHO), driving insights into cancer epidemiology. At EMBL-EBI and the University of Cambridge, he established comprehensive knowledge resources and workflow infrastructures to support FAIR data governance and enable sophisticated data integration and interoperability.
Session chairs
Dr. Yunping Qiu
The Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Albert Einstein College of Medicine, New York, USA
Dr. Yunping Qiu received his Ph.D. degree from Shanghai Jiao Tong University in 2008, China. He worked as a Postdoc and research scientist at the University of North Carolina at Greensboro. Currently, Dr. Qiu is a Research Associate Professor at the department of medicine, Albert Einstein College of Medicine. He also serves as Operations Manager for the stable isotope and metabolomics core facility under the Albert Einstein-Mount Sinai Diabetes Research Center. His research interests include the method development for mass spectrometry-based metabolomics and metabolic flux protocols, and the understanding of metabolic variations associated with diabetes, cancers, infectious diseases, as well as the metabolic interactions with immune responses. Dr. Qiu co-authored more than 100 papers in the metabolomics field.
Prof. Cecília R.C. Calado
Chemical Engineering Department, ISEL- Instituto Superior de Engenharia de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal
Cecília R.C. Calado (https://orcid.org/0000-0002-doutor5264-9755): Coordinating professor with Aggregation at the Lisbon School of Engineering (ISEL – Instituto Superior de Engenharia de Lisboa), Polytechnic University of Lisbon. Coordinator of the Section of Bioengineering of the Chemical Engineering Department, Coordinator of the R&D Laboratory in Health Bioengineering, and Coordinator of the MSc course in Biomedical Engineering. Integrated member of the Institute for Bioengineering and Biosciences (iBB), The Associate Laboratory Institute for Health and Bioeconomy–i4HB-IST. Presents an aggregation in Biochemistry (2022), PhD (2003) and MSc (1998) in Biotechnology, and a 5 years licenciatura degree in Biochemistry (1995). Presents a broad R&D experience in “Bioprocess Engineering”, and “Drugs and biomarkers discovery”. Supervised more than 100 students, including PhD, MSc and BSc students. PI. or co-P.I. of projects financed by FCT, ADI, and IPL. Coordinated a Team on the CoHiTec – 2012 Program and team member that won a EIT Digital Venture Program 2020.
Prof. Hunter N. B. Moseley
Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, USA
Hunter N.B. Modeley, Ph.D., is a professor in the Department of Molecular and Cellular Biochemistry at the University of Kentucky. His broad research interest is in developing computational methods, models, and tools for analyzing, integrating, and interpreting many types of biological and biophysical data. These developments enable new understanding of biological systems and related disease processes, using applications from omics (especially metabolomics) data analysis, systems biology, and structural bioinformatics.
Prof. Dr. Shu-Hai Lin
Xiamen University, Xiamen, China
Shuhai Lin, Professor at School of Life Sciences, Xiamen University, focusing on metabolomics and metabolic regulation. Recently, his research team integrated mass spectrometry technology, artificial intelligence, and biological experiments for lipidomics, unknown metabolite identification in untargeted metabolomics as well as metabolite functions in human diseases. He has published more than 20 peer-reviewed articles in Nature Communications、PNAS、Autophagy、Science Signaling、Cancer Research as corresponding author. He also serves as the committee member for several academic societies including Biophysical Society of China.
Dr. Madhu Basetti
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
Dr Madhu Basetti is an accomplished research scientist at the CRUK Cambridge Institute, specializing in the development of non-invasive imaging and spectroscopic methods (MRI, MRS, NMR) to probe cancer metabolism and biology. His multidisciplinary work spans methodological innovation, metabolomics, and translational research, and is supported by a portfolio of scholarly publications and editorial contributions. He has published more than 75 scientific articles in internationally renowned journals.
Prof. Dr. Giuseppe Paglia
School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Giuseppe Paglia is an Associate Professor of Biochemistry and the head of the Metabolomics and Lipidomics Group of the School of Medicine and Surgery at the University of Milano-Bicocca. His current research is in the field of biomarker discovery, cell metabolism, systems biology and translational medicine through the use of mass spectrometry(MS)-based omics technology. He published more than 90 peer-reviewed manuscripts and holds 2 patents on these topics. He is a firm believer in the power of technological innovation to drive scientific progress, and his passion lies at the intersection of biology and technology.
Prof. Dr. Chi Chen
Department of Food Science and Nutrition, University of Minnesota, Minneapolis, USA
Dr. Chi Chen is a professor at both the Department of Food Science and Nutrition and the Department of Animal Science, University of Minnesota. His research covers nutrient metabolism, nutritional biochemistry, animal metabolism, toxicology, and xenobiotic metabolism, with a focus on the metabolic changes induced by dietary, chemical, microbial, and pathophysiological conditions in animals and humans.
Dr. Ala F. Nassar
School of Medicine, Yale University, Connecticut, USA
Ala F. Nassar, PhD, is a faculty member at Yale University. He has over 25 years of experience in Drug Metabolism and Preclinical Drug Development with leadership roles in both big pharma, smaller biotech firms and academics (UCONN, Brandeis and Yale). He has published more than 100 articles and chapters and holds patents in the fields of drug metabolism and bioanalytical chemistry. He leads and executes ADME-Tox experiments supporting grant projects. He was the head of the drug metabolism and bioanalytical department at Vion Pharmaceuticals, where his studies of the ADME-Tox properties of Laromustine led to a fuller, more accurate and detailed understanding of the human toxicities of the drug.
Dr. Giovanni Ribaudo
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Dr. Giovanni Ribaudo, PhD received his Master’s degree cum laude in Medicinal Chemistry and Technology at the University of Padova (Italy) in 2011 and graduated PhD in 2015 at the same Institution, after carrying out part of the research activity at the State University of New York, Albany (NY, USA). Between 2015 and 2019, Dr. Ribaudo worked as a post-doc at the University of Padova collaborating with a private company in the field of the chemistry of natural compounds. In 2019, Dr. Ribaudo joined the Department of Molecular and Translational Medicine of the University of Brescia, where he is currently lecturing courses of Medicinal chemistry and of Drug analysis for Pharmacy and Biotechnology students. His research activity is based on a combination of synthetic, analytical (HPLC, NMR, mass spectrometry) and computational medicinal chemistry tools, and his main research topics consist in the design and screening of small molecules interacting with peculiar DNA arrangements and Nature-inspired drug-like bioactive compounds. Dr. Ribaudo co-authored more than 130 scientific papers (h-index: 23), all published in recognized international Journals, 2 book chapters and he is inventor of 2 patents.
Prof. Dr. Jeffrey R. Idle
Western New England University, Massachusetts, USA
Prof. Idle obtained his BSc (applied chemistry) in 1972 and a BSc First Class Honors (medicinal chemistry) in 1973 at the University of Hertfordshire, UK and his PhD in Biochemistry at St Mary’s Hospital Medical School (now Imperial College), University of London, UK in 1976. Prof. Idle is a chartered scientist, chartered chemist, and chartered biologist and a Fellow of the Royal Society of Chemistry, the Royal Society of Biology, and the British Pharmacological Society. He is an honorary life member of the Hungarian Society of Clinical and Experimental Pharmacology. He received a DSc (honaris causa) from the University of Hertfordshire in 2021. Prof. Idle was formerly Professor of Pharmacogenetics and Head of the School of Clinical Medical Sciences, University of Newcastle, UK; Professor in Medicine and Molecular Biology, Norwegian University of Science and Technology, Trondheim, Norway; Founding Head, Department of Medical Genetics, St. Olav’s University Hospital, Trondheim, Norway; Visiting Professor, Charles University, Prague, Czech Republic; Visiting Professor, University of Bern, Switzerland; Endowed Professor and Director, Long Island University, Brooklyn, NY. Prof. Idle has published 450 original articles in peer-reviewed international journals, reviews, book chapters, and communications, with an h-index of 86. Prof. Idle has been invited to speak at countless domestic and international conferences.
Event Committee
Department of Chemistry, Stanford University, California, USA
Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy
Agriculture Victoria Research; Department of Energy, Environment and Climate Action; School of Applied Systems Biology, La Trobe University; Bundoora, VIC, Australia
Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore, Australia
Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale “A. Avogadro”, Novara, Italy
Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
Toxicology and Clinical Chemistry Laboratory of “AMES Polydiagnostic Centre”, Italy
Institute of Research on Terrestrial Ecosystems (IRET) of the Italian National Research Council (CNR), Porano, Italy
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche-STEBICEF, Università degli Studi di Palermo, Palermo, Italy
Department of Chemistry and Biology “A. Zambelli”, University of Salerno, Fisciano, Italy
Theoreo Srl–spin off company, University of Salerno, Fisciano, Italy
Department of Nutrition and Food Science, University of Granada, Granada, Spain
Department of Medicine and Surgery, University of Enna “Kore”, Enna, Italy
Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
Dipartimento di Scienze Biomediche e Cliniche “L. Sacco”, Università di Milano, Milan, Italy
Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy
Chemical Engineering Department, ISEL- Instituto Superior de Engenharia de Lisboa, Polytechnic University of Lisbon, Lisbon, Portugal
1. Genetics and Molecular Pathology, SA Pathology (at Women's and Children's Hospital), North Adelaide 5006, Australia
2. Adelaide Medical School, University of Adelaide, Adelaide 5005, Australia
Co-Chair
Dr. Ala F. Nassar
School of Medicine, Yale University, New Haven, Connecticut, USA
Invited Speakers
Department of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P. R. China.
Speech Title: Metabolomics based on laser desorption/ionization mass spectrometry
Lin Huang is an Association Professor (Principal Investigator) at Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine in China. Her research interests focus on the development of material-device-regulated metabolomic mass spectrometry and artificial intelligence-assisted molecular analysis. Published 39 SCI papers as first or corresponding author in journals including Nature Sustainability, Nature Communications (2017, 2020, 2025a, 2025b), Advanced Materials, Matter, and Advanced Functional Materials (2020, 2022, 2025), with 24 papers with impact factor >10. 12 works were selected as cover/featured articles and highlighted by Nature Medicine.
Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Jersey, USA
Speech title: Assessment of the uncertainty in metabolic flux analysis
Dr. Xiaoyang Su is Associate Professor in the Division of Endocrinology, Department of Medicine at Robert Wood Johnson Medical School, Rutgers University. He serves as Co-Director of the Metabolomics Shared Resource, where he leads LC-MS metabolomics and stable-isotope tracing efforts. Dr. Su received his B.S. and M.S. from Tsinghua University and his Ph.D. in Chemical Biology from Cornell University. He had his postdoctoral training at Princeton University. His lab specializes in characterizing orphan SLC transporters and quantification of metabolite flux through advanced LC-MS methods.
Human Nutrition Program, Department of Human Sciences, College of Education and Human Ecology, The Ohio State University, Ohio, USA
Speech Title: Navigating Nutritional Complexity with Metabolomics Insights
Dr. Rachel Kopec received a B.S. in Pharmaceutical Sciences and a B.S. in Business Finance specialization, followed by a Ph.D. in Human Nutrition from the Ohio State University. She was an AgreenSkills postdoctoral fellow at the Institut National de la Recherche Agronomique in France before returning to OSU. She is currently an Associate Professor of Human Nutrition at Ohio State. Dr. Kopec’s group is a leader in leveraging advanced analytical chemistry techniques to study dietary bioactive interactions, especially those occurring in the gastrointestinal tract and in the brain. Ultimately, a better understanding of the role these bioactives play at multiple levels of biology is essential to establish evidence for “precision” nutrition recommendations. She has published over 45 externally reviewer journal articles and raised over $7.4 million in external funding as PI or Co-I for this work. For her outstanding contributions, Dr. Kopec received the Ohio State University Provost’s Mid-Career award in 2025. She also currently serves as the Editor-in-Chief of the Journal of the American Nutrition Association, and leads the Precision Nutrition arm of the Foods for Health Discovery Theme at Ohio State.
CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China
Comprehensive analysis of gut microbiota related metabolites and their relationship with health
Prof. Dr. Xinyu Liu, Principal Investigator (PI) of the Laboratory of High Resolution Separation/Analysis and Metabolomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS). In 2021, she was elected as a member of the Youth Innovation Promotion Association of the Chinese Academy of Sciences. She obtained the foundation for excellent young scientists from Liaoning Province in 2024，from National Natural Science Foundation of China in 2025. She has published more than 80 peer-reviewed papers in the WoS indexed journals, such as Nature Metabolism, Nature Communications, Gut Microbes, Signal Transduction and Targeted Therapy, TrAC-Trends Anal Chem, Analytical Chemistry, and holds more than 20 China patents.
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, UK
Anti-biofilm Compounds from Marine and Terrestrial Endosymbiotic Cultures
Dr Edrada-Ebel obtained her PhD in Pharmaceutical Biology from the Julius-Maximilian University of Würzburg in 1998 and did her postdoctoral years at the Department of Chemistry, University of California Santa Cruz and University of Oklahoma in 1999 and 2000. She was a Senior Research Fellow at the Institute of Pharmaceutical Biology and Biotechnology, University of Düsseldorf from 2001 to 2007. Dr Edrada-Ebel currently is a Senior Lecturer in Pharmaceutical Analysis, the Director of Postgraduate Taught Courses for Biomedical Sciences, and heads the Natural Products Metabolomics Group at the Strathclyde Institute of Pharmacy and Biomedical Sciences and is currently author of more than 150 publications and two patents on marine natural products.
Food Science and Human Nutrition, Graduate Program Director, Colorado State Microbiome Network (CoSMic) Co-Director, Colorado State University, Fort Collins, USA
Exploring the Role of the Gut Microbiome in the Bioavailability of Blueberry Polyphenols
Dr. Tiffany Weir is a Professor of Food Science and Human Nutrition at Colorado State University, where she also serves as the co-Director for the Colorado State Microbiome Network. She earned her Ph.D. in Cell and Molecular Biology from CSU, following a Master’s in Plant Pathology and a Bachelor’s in Biology/Microbiology from Pennsylvania State University. Her research bridges the fields of gut microbiota, dietary interventions, and cardiometabolic health, with a focus on how the microbiome mediates host responses to nutrition. Dr. Weir’s work includes clinical trials on probiotics, functional foods, and polyphenol metabolism, aiming to reduce risks of chronic diseases like colorectal cancer and cardiovascular disease. She also teaches courses in Fermentation Microbiology, Personalized Nutrition, and holds a position as Editor-in-Chief of npj Biofilms and Microbiomes.
Sessions
S2. Technological Advances in Metabolomics
S3. Advanced Metabolomics and Data Analysis Approaches
S4. Metabolomics for Precision Nutrition in Humans and Animals
S5. Applications of Metabolomics in Pharmacology and New Drug Development
S6. Microbial Metabolites with Novel Functions in Diseases and Health
Registration
Instructions for Authors
1. Deadline for abstract submission:
2. Abstract acceptance notification: 11 September 2025.
1. The abstract structure should include the introduction, methods, results, and conclusions sections of about 200–300 words in length.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
- Size in pixel: 1080 width x 1536 height–portrait orientation.
- Size in cm: 38,1 width x 54,2 height–portrait orientation.
- Font size: ≥16.
- Examples of successful submissions can be viewed here at the following links: (1), (2), (3)
- You can use our free template to create your poster. The poster template can be downloaded HERE.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
1. Metabolites Journal Publication
Participants in this conference are cordially invited to contribute a full manuscript to the Conference's Special Issue, published in Metabolites (ISSN: 2218-1989, Impact Factor3.7), with a 20% discount on the publication fee. Please note, if you have IOAP/association discounts, conference discounts will be combined with IOAP/association discounts. Conference discounts cannot be combined with reviewer vouchers. All submitted papers will undergo MDPI’s standard peer-review procedure. The abstracts should be cited and noted on the first page of the paper.
2. Proceeding Paper Publication
All accepted abstracts will be published in the conference report of The 4th International Electronic Conference on Metabolomics in the Biology and Life Science (ISSN: 2218-1989) if you wish to publish an extended proceeding paper (4-8 pages), please submit it to the same journal after the conference.
Authors are asked to disclose that it is a proceeding paper of the IECM2025 conference paper in their cover letter. Carefully read the rules outlined in the 'Instructions for Authors' on the journal’s website and ensure that your submission adheres to these guidelines.
Proceedings submission deadline: 1 December 2025.
Manuscripts for the proceedings issue must be formatted as follows:
Title.
Full author names.
Affiliations (including full postal address) and authors' e-mail addresses.
Abstract.
Keywords.
Introduction.
Methods.
Results and Discussion.
Conclusions.
Acknowledgements.
References.
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to announce that the conference will provide six awards including Best Oral Presentation Awards and Best Poster Awards.
The Awards
Number of Awards Available: 6
The Best Poster Awards are given to the submission judged to make the most significant and interesting poster for the conference.
Sponsors and Partners
Organizers
Media Partners
Conference Secretariat
Ms. Munin Laodumrongkul
Ms. Coco Hou
Email: iecm2025@mdpi.com
For inquiries regarding submissions and sponsorship opportunities, please feel free to contact us.
